%0 Journal Article
%T Investigating Recent Testing among MSM: Results from Community-Based HIV Rapid Testing Attendees in France
%A Nicolas Lorente
%A Karen Champenois
%A J谷rˋme Blanche
%A Marie Pr谷au
%A Marie Suzan-Monti
%A Marion Mora
%A Lionel Fugon
%A Maria Patrizia Carrieri
%A Luis Sagaon-Teyssier
%A Jean-Marie Le Gall
%A Bruno Spire
%A Yazdan Yazdanpanah
%J Journal of Sexually Transmitted Diseases
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/648791
%X Background. We aimed to identify factors associated with recent HIV testing in MSM who attended two experimental community-based and nonmedicalized voluntary counselling and testing programmes (CB-VCT) targeting MSM in France. Methods. This analysis was based on data collected in 2009每2011 through a self-administered pretesting questionnaire. An index measuring the level of participants＊ sexual orientation disclosure was built: the higher the index, the greater the disclosure. Factors associated with recent HIV testing (last test ≒ 1 year) were identified using a multivariate logistic regression model adjusted for the CB-VCT programme of enrolment. Results. 716 MSM provided data on testing history. Overall, 49% were recently tested for HIV and 51% were not. Recently tested MSM had a higher homosexuality disclosure index (adjusted OR [95% confidence interval]: aOR = 1.2 [1.1每1.4]), reported more inconsistent condom use during anal sex with men (aOR = 1.6 [1.2每2.1]), and were less likely to have sex under the influence of club drugs (aOR = 0.6 [0.4每1.0]). Conclusion. New testing strategies should focus on those who live their homosexuality relatively secretly and those who use club drugs before sex. Governments should develop policies which encourage improved social acceptance of homosexuality as concealment of sexual orientation represents a major barrier to testing. 1. Introduction In resource-rich countries, men who have sex with men (MSM) are greatly affected by the HIV burden [1每7], including France where they account for 40% of the annual new diagnoses [8]. The French HIV incidence in MSM is 60 times higher than that in the overall population [2]. Although a large proportion of MSM have already been tested for HIV in France [7, 9, 10], it is estimated that they account for 31% of the hidden epidemic [11] and for 19% of the diagnoses made at an advanced disease stage in 2011 (CD4 < 200/mm3, [8]). HIV testing has now become a tool to limit the HIV epidemic [12] and is a recognized element of combination prevention based on biomedical (preexposure prophylaxis, treatment as prevention) and behavioural (mainly serosorting and positioning) tools [13每17]. Indeed, knowledge of HIV serostatus is the cornerstone of successful combination prevention, as the latter＊s implementation is adapted according to the individual＊s serological status. In France, just as in the USA, guidelines encourage the extension of HIV testing and recommend annual testing of certain population groups at high risk of acquiring HIV, in particular MSM [18每20]. Early detection of HIV
%U http://www.hindawi.com/journals/jstd/2013/648791/